UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ono Pharma Korea names new CEO
Ono Pharma Korea said Monday that it appointed Yang Min-yeol as its new chi...
by Lee Han-soo
|
2019-07-16 11:24
라인
Daewoong, Medytox differ in interpreting US trade agency’s order
Daewoong Pharmaceutical claimed that it has gained the upper hand in the U....
by Lee Han-soo
|
2019-07-15 17:44
라인
Self-claimed Korea Otsuka employee causes stir on far-right website
A “self-proclaimed” Korea Otsuka Pharmaceutical employee is stirring up con...
by Lee Han-soo
|
2019-07-15 15:57
라인
China OKs Huonland's hyaluronic acid eye drop
Huonland, a joint venture between Huons and Beijing Northland, said that it...
by Lee Han-soo
|
2019-07-15 13:57
라인
Japanese pharma companies closely following 'Boycott Japan' campaign
Japan is moving to remove Korea from the white list of importers of its hi-...
by Lee Han-soo
|
2019-07-12 17:07
라인
Daewoong to co-promote Lundbeck Korea's Alzheimer's disease treatment
Daewoong Pharmaceutical said that it has agreed to promote Lundbeck Korea’s...
by Lee Han-soo
|
2019-07-12 15:13
라인
Regulator OKs Merck Korea's relapsing-remitting multiple sclerosis treatment
Merck Biopharma Korea said that the Ministry of Food and Drug Safety has gr...
by Lee Han-soo
|
2019-07-11 17:39
라인
Humira permitted for nursing, pregnant patients
The local regulator allowed nursing and pregnant patients to use autoimmune...
by Kim Yun-mi
|
2019-07-11 16:41
라인
SCM Life Science, MitoImmune Therapeutics to develop new treatment
SCM Life Science said that it has agreed with MitoImmune Therapeutics to de...
by Lee Han-soo
|
2019-07-11 16:40
라인
Acute renal failure reported in ibandronate injections
The government warned that ibandronate injections for the treatment of oste...
by Lee Hye-seon
|
2019-07-11 13:34
라인
Yuyu holds 3rd annual compliance program workshop
Yuyu Pharmaceutical said that it has finished its third annual “Self-Compli...
by Lee Han-soo
|
2019-07-11 12:09
라인
Contera Pharma gets ₩3 billion funding from venture capital
Contera Pharma, a Copenhagen-based subsidiary of Korean drugmaker Bukwang P...
by Jeong Sae-im
|
2019-07-10 17:28
라인
Court to test Nabota’s spore-forming to end Daewoong-Medytoxin dispute
The Seoul Central District Court has begun to test whether Nabota, botulinu...
by Jeong Sae-im
|
2019-07-10 12:44
라인
'Teva's Fremanezumab improves migraine-related disorders, quality of life'
Teva-Handok said that it has presented the exploratory endpoint results of ...
by Lee Han-soo
|
2019-07-09 16:57
라인
ISU Abxis, Kyungpook National University to co-develop Alzheimer's disease treatment
ISU Abxis said it has signed an agreement to co-develop an Alzheimer's ...
by Lee Han-soo
|
2019-07-09 16:06
라인
Sanofi Aventis names new general manager for consumer healthcare
Sanofi Aventis said that it has appointed Fabien Schmitt as the general man...
by Lee Han-soo
|
2019-07-09 15:16
라인
GSK's Alitoc becoming salvation treatment for chronic hand eczema patients
GSK Korea said Tuesday a fast and accurate treatment is needed to cure chro...
by Lee Han-soo
|
2019-07-09 14:44
라인
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance
Pfizer Korea has failed to reduce the number of target participants in post...
by Lee Hye-seon
|
2019-07-08 16:39
라인
Eutilex wins patent for immunotherapy in Australia
Eutilex said that it has patented EU101, an immunotherapy targeting 4-1BB, ...
by Lee Han-soo
|
2019-07-08 14:27
라인
Yuhan invests ₩6 billion in Imnewrun Biosciences
Yuhan Corp. said it has invested 6 billion won ($5.09 million) in Imnewrun ...
by Lee Han-soo
|
2019-07-08 12:05
-
이전
31
32
33
34
35
36
37
38
39
40
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top